health ๐ฉบ Ozempic's impact goes way beyond weight loss
Obesity rates in the US haven't significantly changed between 2013 and 2023, despite efforts to address it. Gallup data shows the US adult obesity rate dropped to 36.4 percent in July, while GLP-1 drug users rose from 3 percent in 2024 to 11 percent in 2026. These drugs, originally for diabetes, show benefits for sleep apnea, kidney health, liver inflammation, and knee pain. This highlights how major medical breakthroughs often come from secondary effects of drugs. ๐ฉบ